108 related articles for article (PubMed ID: 28988762)
1. A series of novel indazole derivatives of Sirt 1 activator as osteogenic regulators.
Atobe M; Yamakawa N; Wada Y; Goto T; Kawanishi M; Ito T; Saito M; Takeda M; Tabata T; Arai H
Bioorg Med Chem Lett; 2017 Nov; 27(21):4828-4831. PubMed ID: 28988762
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.
Zhao CR; Wang RQ; Li G; Xue XX; Sun CJ; Qu XJ; Li WB
Bioorg Med Chem Lett; 2013 Apr; 23(7):1989-92. PubMed ID: 23454017
[TBL] [Abstract][Full Text] [Related]
3. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
[TBL] [Abstract][Full Text] [Related]
4. Indazole derivatives and their therapeutic applications: a patent review (2013-2017).
Denya I; Malan SF; Joubert J
Expert Opin Ther Pat; 2018 Jun; 28(6):441-453. PubMed ID: 29718740
[TBL] [Abstract][Full Text] [Related]
5. 3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.
Fraley ME; Steen JT; Brnardic EJ; Arrington KL; Spencer KL; Hanney BA; Kim Y; Hartman GD; Stirdivant SM; Drakas BA; Rickert K; Walsh ES; Hamilton K; Buser CA; Hardwick J; Tao W; Beck SC; Mao X; Lobell RB; Sepp-Lorenzino L; Yan Y; Ikuta M; Munshi SK; Kuo LC; Kreatsoulas C
Bioorg Med Chem Lett; 2006 Dec; 16(23):6049-53. PubMed ID: 16978863
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel azaindazole CCR1 antagonist clinical candidates.
Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
[TBL] [Abstract][Full Text] [Related]
7. Indazole and its Derivatives in Cardiovascular Diseases: Overview, Current Scenario, and Future Perspectives.
Uppulapu SK; Alam MJ; Kumar S; Banerjee SK
Curr Top Med Chem; 2022; 22(14):1177-1188. PubMed ID: 34906057
[TBL] [Abstract][Full Text] [Related]
8. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 was involved in TNF-α-promoted osteogenic differentiation of human DPSCs through Wnt/β-catenin signal.
Feng G; Zheng K; Song D; Xu K; Huang D; Zhang Y; Cao P; Shen S; Zhang J; Feng X; Zhang D
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1001-1011. PubMed ID: 27530621
[TBL] [
